AMRX Long-Term Debt
Amneal Pharmaceuticals Inc Class A · Long-Term Debt
AMRX Long-Term Debt
Latest reported$2.71Bperiod ending
AMRX FY Long-Term Debt ($952.63M → $2.71B)
Annual long-term debt
High-resolution chart · PNG
AMRX long-term debt history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 2,714,898,000 | |
| 2,252,884,000 | |
| 2,522,899,000 | |
| 2,740,496,000 | |
| 2,830,019,000 | |
| 2,941,349,000 | |
| 2,732,982,000 | |
| 2,669,681,000 | |
| 1,395,261,000 | |
| 1,160,487,000 | |
| 952,633,000 |